|Description||A-1165442 is a potent, competitive and orally available modality-differentiated second-generation TRPV1 antagonist with good analgesic efficacy and a temperature-neutral profile (IC50= 9 nM for human TRPV1).|
|Brife Description||A potent, competitive and orally available TRPV1 antagonist (IC50= 9 nM for human TRPV1)|
|Synonyms||A1165442; A 1165442; A-1165442; 1-[(4R)-7-chloro-2,2-bis(fluoromethyl)-3,4-dihydrochromen-4-yl]-3-(3-methylisoquinolin-5-yl)urea; 1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||574.4±50.0 ℃ at 760 Torr|
MRS 1477, a dihydropyridine derivative, is a TRPV1 positive allosteric modulator, and potentiates vanilloid and proton activation of TRPV1 channels.
AP18 is a selective Transient receptor potential A1(TRPA1) channel blocker which reversibly inhibits TRPA1 with IC50 values of 3.1 and 4.5 µM at human and mouse...
ABT 102 is a selective transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with IC50 values to be 5-7 nM. No recent reports of development iden...
SB-366791 is a potent, and selective cinnamide TRPV1 antagonist (pA2 = 7.71 at hVR1) with IC50 of 5.7±1.2 nM.
A 967079 is a selective TRPA1 channel blocker (IC50 = 67 and 289 nM at human and rat TRPA1 receptors, respectively) with 1000-fold selectivity for TRPA1 over ot...
SAR7334, a TRPC6 inhibitor, could be valuable in studying sorts of diseases related to TRPC.
EIPA is a TRPP3 channel inhibitor (IC50 = 10.5 μM). EIPA also acts as an Na+/H+ exchange inhibitor that suppresses the Na+/H+ exchanger (NHE).
AMG8562 is a novel vanilloid receptor TRPV1 modulator.